Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S0713: Neoadjuvant Oxaliplatin, Capecitabine, Cetuximab and Radiation in Rectal Cancer
NCT00686166Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2009
- Primary completion
- Jul 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in rectal cancer, sponsored by SWOG Cancer Research Network. Started Feb 2009; status: completed.
02
Drugs
KL-140
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00686166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686166.